Valuation: OrganiGram Holdings Inc

Market Cap 203M 143M 126M 116M 108M 13.62B 208M 1.39B 539M 6.68B 538M 526M 23.26B P/E 2026 *
11.1x
P/E 2027 * 36.1x
Enterprise Value 203M 143M 126M 116M 108M 13.62B 208M 1.39B 539M 6.68B 538M 526M 23.26B EV / Sales 2026 *
0.6x
EV / Sales 2027 * 0.46x
Free-Float
69.76%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 2026-01-14
Director of Finance/CFO - 2024-01-07
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 2018-03-28
Director/Board Member 56 2018-12-16
Director/Board Member 70 2018-12-16
Change 5-day change 1-year change 3-year change Capi.($)
-1.06%-9.65% - - 143M
-0.50%+8.15%+74.56%+232.33% 227M
+3.53%+13.55%+24.82%+95.56% 122M
+8.51%+15.91%+52.24%-17.74% 104M
-9.99%+1.11%+39.06%-7.29% 88.87M
-4.10%+6.91%-36.04%-48.05% 62.14M
Average -0.60%+7.41%+30.93%+50.96% 120.87M
Weighted average by Cap. -0.13%+7.83%+44.07%+97.73%

Financials

2026 *2027 *
Net sales 340M 239M 210M 193M 180M 22.73B 346M 2.32B 900M 11.16B 898M 878M 38.83B 441M 310M 273M 251M 234M 29.51B 450M 3.02B 1.17B 14.48B 1.17B 1.14B 50.41B
Net income 18.88M 13.29M 11.67M 10.74M 10.01M 1.26B 19.26M 129M 50.06M 620M 49.9M 48.83M 2.16B 6.53M 4.6M 4.04M 3.72M 3.46M 437M 6.66M 44.69M 17.32M 215M 17.26M 16.89M 747M
Net Debt - -
Logo OrganiGram Holdings Inc
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-